Evidence map›Paper›PMID 35675953›Full record

ArticleBMJ open diabetes research & care2022

Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset.

Chris Worth, Yesica Tropeano, Pon Ramya Gokul, Karen E Cosgrove, Maria Salomon-Estebanez, Senthil Senniappan, Antonia Dastamani, Indraneel Banerjee

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Chris WorthDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK chris.worth@mft.nhs.uk.ORCID 0000-0001-6609-2735
Yesica TropeanoDepartment of Paediatric Endocrinology, Great Ormond Street Hospital for Children, London, UK.
Pon Ramya GokulDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.
Karen E CosgroveLife Sciences, University of Manchester, Manchester, UK.
Maria Salomon-EstebanezDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.
Senthil SenniappanDepartment of Paediatric Endocrinology, Alder Hey Children's Hospital, Liverpool, UK.
Antonia DastamaniDepartment of Paediatric Endocrinology, Great Ormond Street Hospital for Children, London, UK.
Indraneel BanerjeeDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.
University of Manchester · GBGreat Ormond Street Hospital · GBRoyal Manchester Children's Hospital · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHypoglycemia is often recurrent and severe in patients with congenital hyperinsulinism (CHI). However, there is little information regarding frequency or patterns of episodes to inform clinical management and future trial design. RESEARCH DESIGN AND

methodsWe aimed to describe frequency and patterns of hypoglycemia by varying thresholds through a large continuous glucose monitoring (CGM) dataset. Through the UK CHI centers of excellence, data were analyzed from patients with CHI over a 5-year period. Hypoglycemia thresholds of 3.0 (H3.0), 3.5 (H3.5) and 3.9 (H3.9) mmol/L were used to test threshold change on hypoglycemia frequencies.

resultsFrom 63 patients, 3.4 million data points, representing 32 years of monitoring, were analyzed. By UK consensus threshold H3.5, patients experienced a mean 1.3 hypoglycemic episodes per day. Per cent time hypoglycemic increased from 1.2% to 3.3% to 6.9% when threshold changed from H3.0 to H3.5 and H3.9. Merged data showed periodicity of hypoglycemia risk in 24-hour periods in all patients.

conclusionsWe have evaluated a large dataset to provide a comprehensive picture of the frequency and patterns of hypoglycemia for patients with CHI in the UK. These data establish a baseline risk of hypoglycemia by CGM and provide a framework for clinical management and clinical trial design.

Indexed as

Congenital HyperinsulinismDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHumansHypoglycemic AgentsUnited KingdomBlood GlucoseHypoglycemic Agentsblood glucose self-monitoringhyperinsulinismhypoglycemia

Identifiers

PMID35675953
PMCPMC9185472
OpenAlexW4282942238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.